Daiichi Sankyo Investor Relations Material

Daiichi Sankyo Company Limited is a global pharmaceutical company, focusing on the research, development, manufacturing, and marketing of pharmaceutical products. The company operates in the healthcare sector, providing drugs and services in various therapeutic areas, including cardiovascular, oncology, and metabolic disorders, among others. Daiichi Sankyo's approach combines expertise in biologics with advanced research technologies to develop novel therapies and solutions for patients worldwide. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.